BSD-2000 Hyperthermia System combined with chemotherapy promising for children with high-risk tumors
BSD Medical Corporation today reported clinical study data showing that hyperthermia, using the BSD-2000 Hyperthermia System, combined with chemotherapy has the potential to improve control rate and long-term survival for the treatment of children with high-risk cancer who have a dismal prognosis.

Read more on News-Medical-Net